ICOA
ALT icon

Investment Centers of America’s Altimmune ALT Stock Holding History

Investment Centers of America’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-60
Closed -$15K – 594
2017
Q1 		$15K Buy
+60
New +$32.1K ﹤0.01% 636

Other funds holding ALT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Investment Centers of America's ALT Position: Q2 2017 in Review

Investment Centers of America sold out of Altimmune (ALT) in Q2 2017, closing a stake of 60 shares — an estimated $15K sold.

Investment Centers of America first reported a position in ALT in Q1 2017 and held it in 1 quarter. The position peaked at $15K in Q1 2017. 42 funds tracked by Wall St. Rank hold ALT as of Q2 2017.

  • Investment Centers of America reported no remaining Altimmune position as of Q2 2017 after selling out during the quarter.
  • Investment Centers of America sold 60 Altimmune shares in Q2 2017, an estimated $15K.
  • Investment Centers of America first reported a position in Altimmune in Q1 2017 and held it in 1 quarter.
  • Investment Centers of America's Altimmune position peaked at $15K in Q1 2017.
  • 42 funds tracked by Wall St. Rank held Altimmune as of Q2 2017.

Based on Investment Centers of America's 13F filing for Q2 2017, filed 11 Aug 2017.